Dr Agarwals Eye Hospital NCLT hearing set for Aug 19
Dr Agarwals Eye Hospital Ltd has announced that the National Company Law Tribunal (NCLT), Chennai Bench, will hear its amalgamation petition with Dr Agarwal's Health Care Limited on August 19, 2026. The joint petition was presented under Sections 230 to 232 of the Companies Act, 2013. Shareholders and creditors wishing to support or oppose the scheme must submit their notice of intention to the petitioner's advocate two days prior to the hearing.

*this image is generated using AI for illustrative purposes only.
Dr Agarwals Eye Hospital Ltd has scheduled a hearing before the National Company Law Tribunal (NCLT), Chennai Bench, for August 19, 2026, to seek approval for its amalgamation with Dr Agarwal's Health Care Limited. The joint company petition, filed under Sections 230 to 232 of the Companies Act, 2013, was presented on July 15, 2026. The scheme involves the transferor company, Dr Agarwals Eye Hospital Limited, and the transferee company, Dr Agarwal's Health Care Limited, along with their respective shareholders and creditors.
Pursuant to the NCLT's order dated July 15, 2026, the companies published newspaper advertisements in Business Standard and Makkal Kural on July 20, 2026, to intimate the notice of the hearing. The filing was made to BSE Limited under Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Petition Details and Representation
The petition, identified as Company Petition (CAA) No. 57/CHE/2026, is connected with Company Application (CAA) No. 19/CHE/2026. Dr Agarwals Eye Hospital Limited is represented by Ms. Meenakshi Jayaraman, Company Secretary and Compliance Officer, while Dr Agarwal's Health Care Limited is represented by Mr. Thanikaianthan Arumugam, Company Secretary and Compliance Officer. Both entities are registered under the Companies Act of 1956 and share the same registered office address in Chennai, Tamil Nadu.
Shareholder and Creditor Participation
Any person desirous of supporting or opposing the petition must send a notice of intention to the advocate of the petitioner companies. The notice, signed by the individual or their advocate, must include the name and address and reach the advocate's office in Chennai no later than two days before the hearing date. Those opposing the petition are required to furnish the grounds of opposition or a copy of their affidavit along with the notice. A copy of the petition is available to any person upon payment of the prescribed charges.
| Entity | Role | CIN | Representative |
|---|---|---|---|
| Dr Agarwals Eye Hospital Limited | Petitioner Company No. 1 / Transferor Company | L85110TN1994PLC027366 | Ms. Meenakshi Jayaraman |
| Dr Agarwal's Health Care Limited | Petitioner Company No. 2 / Transferee Company | L85100TN2010PLC075403 | Mr. Thanikaianathan Arumugam |
Historical Stock Returns for Dr. Agrawals Eye Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.21% | +0.91% | +0.96% | +5.52% | +5.52% | +5.52% |
What operational synergies is the amalgamation expected to create between Dr Agarwals Eye Hospital and Dr Agarwal's Health Care?
How will the share swap ratio be determined for shareholders of the transferor company upon the merger's completion?
What impact will this consolidation have on the competitive landscape of the eye care sector in Tamil Nadu?


































